Document Detail


Chromodomain proteins in development: lessons from CHARGE syndrome.
MedLine Citation:
PMID:  20507341     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In humans, heterozygous mutations in the adenosine triphosphate-dependent chromatin remodeling gene CHD7 cause CHARGE syndrome, a common cause of deaf-blindness, balance disorders, congenital heart malformations, and olfactory dysfunction with an estimated incidence of approximately 1 in 10,000 newborns. The clinical features of CHARGE in humans and mice are highly variable and incompletely penetrant, and most mutations appear to result in haploinsufficiency of functional CHD7 protein. Mice with heterozygous loss of function mutations in Chd7 are a good model for CHARGE syndrome, and analyses of mouse mutant phenotypes have begun to clarify a role for CHD7 during development and into adulthood. Chd7 heterozygous mutant mice have postnatal delayed growth, inner ear malformations, anosmia/hyposmia, and craniofacial defects, and Chd7 homozygous mutants are embryonic lethal. A central question in developmental biology is how chromodomain proteins like CHD7 regulate important developmental processes, and whether they directly activate or repress downstream gene transcription or act more globally to alter chromatin structure and/or function. CHD7 is expressed in a wide variety of tissues during development, suggesting that it has tissue-specific and developmental stage-specific roles. Here, we review recent and ongoing analyses of CHD7 function in mouse models and cell-based systems. These studies explore tissue-specific effects of CHD7 deficiency, known CHD7 interacting proteins, and downstream target sites for CHD7 binding. CHD7 is emerging as a critical regulator of important developmental processes in organs affected by human CHARGE syndrome.
Authors:
W S Layman; E A Hurd; D M Martin
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2010-04-08
Journal Detail:
Title:  Clinical genetics     Volume:  78     ISSN:  1399-0004     ISO Abbreviation:  Clin. Genet.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-05     Completed Date:  2010-10-19     Revised Date:  2011-09-12    
Medline Journal Info:
Nlm Unique ID:  0253664     Medline TA:  Clin Genet     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  11-20     Citation Subset:  IM    
Affiliation:
Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Multiple
Animals
DNA Helicases / deficiency,  physiology*
DNA-Binding Proteins / deficiency,  physiology*
Deaf-Blind Disorders / physiopathology*
Growth and Development
Humans
Mice
Syndrome
Grant Support
ID/Acronym/Agency:
R01 DC009410-01A1/DC/NIDCD NIH HHS; R01 DC009410-01A1S1/DC/NIDCD NIH HHS; R01 DC009410-02/DC/NIDCD NIH HHS; R01 DC009410-03/DC/NIDCD NIH HHS; R01 DC009410-04/DC/NIDCD NIH HHS; R01DC009410/DC/NIDCD NIH HHS; R01NS054784/NS/NINDS NIH HHS; T32DC00011/DC/NIDCD NIH HHS
Chemical
Reg. No./Substance:
0/Chd7 protein, mouse; 0/DNA-Binding Proteins; EC 3.6.1.-/DNA Helicases; EC 5.99.-/CHD7 protein, human
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adipocytokines and the metabolic syndrome among older persons with and without obesity - the InCHIAN...
Next Document:  The constitutional t(11;22): implications for a novel mechanism responsible for gross chromosomal re...